Metrics for assessing the value of patient engagement in drug development: Identifying potential barriers and the way forward?

被引：0
|
作者：
Auwal, Fatima Idris [1 ]
机构：
[1] Kings Coll London, London, England
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2023年 / 180卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P0359
引用
收藏
页码：469 / 470
页数：2
相关论文
共 50 条
  • [11] Assessing Wind Energy Projects Potential in Pakistan: Challenges and Way Forward
    Turi, Jamshid Ali
    Rosak-Szyrocka, Joanna
    Mansoor, Maryam
    Asif, Hira
    Nazir, Ahad
    Balsalobre-Lorente, Daniel
    ENERGIES, 2022, 15 (23)
  • [12] ASSESSING THE VALUE OF DECISION TREES AS A METHOD FOR IDENTIFYING PATIENT SUBGROUPS
    Risson, V
    Jayanti, H.
    Filho, E.
    Rigg, J.
    Skelly, A.
    Bezlyak, V
    Regnier, S. A.
    VALUE IN HEALTH, 2017, 20 (09) : A744 - A744
  • [13] ALS drug development: Reflections from the past and a way forward
    Swati Aggarwal
    Merit Cudkowicz
    Neurotherapeutics, 2008, 5 : 516 - 527
  • [14] ALS drug development: Reflections from the past and a way forward
    Aggarwal, Swati
    Cudkowicz, Merit
    NEUROTHERAPEUTICS, 2008, 5 (04) : 516 - 527
  • [15] Identifying barriers to care and research in hidradenitis suppurativa: findings from a patient engagement event
    Shukla, N.
    Paul, M.
    Halley, M.
    Lowes, M. A.
    Hester, V.
    Aguilar, C.
    Guilbault, S.
    Long, T. S.
    Taylor, A.
    Thompson, A. C.
    Yannuzzi, C. A.
    Linos, E.
    Naik, H. B.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 182 (06) : 1490 - 1492
  • [16] Standards Development for Smart Systems-A Potential Way Forward
    Folmer, Erwin
    Jakobs, Kai
    IEEE TRANSACTIONS ON ENGINEERING MANAGEMENT, 2021, 68 (01) : 75 - 86
  • [17] Patient engagement in drug development: dialogically problematizing participation
    Egher, Claudia
    Bereczky, Tamas
    Snede, Lisbeth
    Zvonareva, Olga
    SCIENCE AS CULTURE, 2025, 34 (01) : 31 - 51
  • [18] Identifying potential barriers and solutions to patient partner compensation (payment) in research
    Dawn P. Richards
    Kelly D. Cobey
    Laurie Proulx
    Shoba Dawson
    Maarten de Wit
    Karine Toupin-April
    Research Involvement and Engagement, 8 (1)
  • [19] IDENTIFYING PATIENT SUBPOPULATIONS IN EARLY DEVELOPMENT TO SUBSTANTIATE VALUE
    Suponcic, S.
    DiBonaventura, M.
    Victor, T.
    VALUE IN HEALTH, 2013, 16 (03) : A42 - A42
  • [20] A PROPOSED RUBRIC FOR PATIENT ENGAGEMENT IN DRUG DEVELOPMENT: WHAT CONSTITUTES "SOUND" ENGAGEMENT?
    Perfetto, E. M.
    Oehrlein, E. M.
    VALUE IN HEALTH, 2016, 19 (03) : A294 - A294
12345